Bromazine
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine | |
Clinical data | |
MedlinePlus | a682065 |
Legal status | ? |
Routes | Oral |
Pharmacokinetic data | |
Bioavailability | High |
Protein binding | 96% |
Metabolism | Mostly hepatic (CYP-mediated), also renal |
Half-life | 1 to 4 hours |
Identifiers | |
CAS number | 1808-12-4 1808-12-4 |
ATC code | R06AA01 |
PubChem | CID 2444 |
DrugBank | DB01237 |
ChemSpider | 2350 |
UNII | 202J683U97 |
ChEBI | CHEBI:59177 |
ChEMBL | CHEMBL1201245 |
Chemical data | |
Formula | C17H20BrNO |
Mol. mass | 334.251 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Bromazine (trade names Ambrodyl, Ambrodil and others), also known as bromodiphenhydramine, is an antihistamine and anticholinergic.[1] It is a halogenated form of diphenhydramine and in many respects is somewhat stronger than the parent compound.
References
|
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.